… which is overexpressed in colorectal adenocarcinoma and metastases. Fap2 … administration
results in significant changes of estrogen-… bowel diseases (IBD), correlating with the grade of …

… estrogen receptor 1 (GPER1). ERβ has been linked to anti-inflammatory and colorectal
cancer-protective effects, and we have previously demonstrated that deletion of ERβ in intestinal …

… Gynecologic malignancies commonly express estrogen receptor (ER) and/or progesterone
receptor (PR) and endocrine therapy is often considered as treatment for advanced, …

… Bcl-2 in colon adenocarcinoma all through the phosphorylation … of this formulation on
inflammatory bowel disease (IBD) and … intestinal carcinogenesis by both antioxidant and estrogen …

… the metabolism of estrogens with a potential impact on estrogen receptor-positive tumor …
upregulated in colon tissue samples from patients with adenomas and adenocarcinomas as …

… Caco-2 cells are an immortalized cell line of human colorectal adenocarcinoma [48].
Differentiated Caco-2 cells produce the same characteristics and specific digestive enzymes (eg, …

… observed for esophageal adenocarcinoma (≈33.3%) and in women the largest PAF is … in
colon cancer and the protective endogenous estrogenic effects against colon cancer in women …

… in other tumor types including lung adenocarcinoma, pancreatic adenocarcinoma, colon and
gastric adenocarcinoma, … markers: estrogen receptor (ER), progesterone receptor (PR), and …

… tissues from IBD patients and PPIA and RPLP0 for studies on bowel tissues from patients
with colorectal adenocarcinomas [45]. For leukocyte analysis, TBP and SDHA were used as …

… estrogen receptor (ER) and progesterone receptor (… adenocarcinoma cells are positive for
Mucin 1 (MUC1) and negative for Mucin 2 (MUC2), whereas most GI cancer adenocarcinoma …